2 diabetes
Conditions
Interventions
Qi-Yin deficiency group:None
Liver-kidney yin deficiency syndrome group:None
Yin-Yang deficiency group:None
Control group:None
Sponsors
Eye Hospital China Academy of Chinese Medical Sciences
Eligibility
Sex/Gender
All
Age
50 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients aged 50-80 years; 2.The patient meets the Western medical diagnostic criteria for type 2 diabetes; 3.During the patient's hospitalization, DR has been confirmed and should meet the staging and TCM syndrome diagnosis criteria of T2DR, and the medical records must be complete. 4.Willing to accept the research plan and agree to undergo relevant examinations; 5.Voluntarily sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1. Patients with acute complications such as diabetic ketosis, diabetic hyperosmolar coma, etc.; 2. Patients with gestational diabetes, type 1 diabetes and other special types of diabetes; 3. Those who have recently had various stress states such as trauma and surgery; 4. Patients with acute and chronic infections, such as respiratory tract infections, urinary tract infections, etc.; 5. Patients with severe liver and kidney insufficiency or hepatitis, liver cirrhosis, chronic obstructive pulmonary disease; 6. Patients with severe hypertension, cardiovascular and cerebrovascular diseases or peripheral diseases, such as cardiac insufficiency, coronary heart disease, cerebral infarction, cerebral hemorrhage, etc.; 7. Combined with other endocrine and metabolic diseases, such as thyroid, pituitary and other diseases; 8. Severe macular degeneration, cataract, fundus arteriosclerosis, hemorrhage, uveitis and other ocular diseases; 9. Patients who have been taking glucocorticoids for a long time or have recently used high-dose corticosteroids; 10. Patients with various tumors; 11. Non-physiological menopause; 12. History of long-term use of drugs that affect bone metabolism; 13. History of primary or secondary bone disease; 14. History of osteoporosis (OP) medication (estrogen, bisphosphonate, active vitamin D, etc.).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Glu;HbA1c;P1NP;ß-CTX;Amino acid combination;Bile acid combination;Homocysteine combination;Renin-aldosterone complex;Catecholamine and methoxy compound combination;Vitamin ADEK combination;Organic acid metabolism pathway;Vitamin metabolism pathway;Hormone metabolism pathway; | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood lipid;RBP;Cys-C;U-TP;Cr;UA;VEGF;Cytokine;Thrombosis;Hs-CRP;OC;PTH;COR; | — |
Countries
China
Contacts
Public ContactRanxing Zhang
Eye Hospital China Academy of Chinese Medical Sciences
Outcome results
None listed